ACTIVE

VERZELE PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result38,4 k €+57,7 %over 1 year

Gross margin186,4 k €-8,3 %over 1 year

Equity166,3 k €+6,7 %over 1 year

Workforce2,0 ETP+53,8 %over 1 year

Identity

Source · BCE/KBO

VERZELE PHARMA is a Private limited company incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oudenaarde. It employs on average 2,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0896.764.703
Incorporation: 28/03/2008
Legal form: Private limited company
Registered office: Diependale 8
9700 Oudenaarde · FlandreSee on map
Contributed capital: 18 600,00 €
Latest accounts: 31/12/2025
Average workforce: 2,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 18 filings

Trend over 18 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	186,4 k €	-8.3%	203,2 k €	-7.1%	218,7 k €	-6.2%	233,2 k €	+40.6%	165,9 k €
EBITDA	64,9 k €	-26.8%	88,7 k €	-17.6%	107,6 k €	-13.2%	124 k €	+76.9%	70,1 k €
Operating result	43,3 k €	+50.8%	28,7 k €	-37.6%	46 k €	-27.3%	63,3 k €	+554%	9,7 k €
Net result	38,4 k €	+57.7%	24,4 k €	-36.6%	38,4 k €	-40.8%	64,9 k €	+266%	17,7 k €
Balance sheet
Equity	166,3 k €	+6.7%	155,9 k €	+0.2%	155,6 k €	+5.7%	147,1 k €	+24.4%	118,3 k €
Total assets	500,6 k €	-9.1%	550,9 k €	-14.0%	640,7 k €	+0.7%	636,1 k €	-12.3%	725,2 k €
Cash	169,1 k €	+3.4%	163,6 k €	+9.8%	148,9 k €	+41.6%	105,2 k €	+22.5%	85,9 k €
Debts	326,1 k €	-15.7%	386,9 k €	-19.0%	477,4 k €	-0.8%	481,4 k €	-19.7%	599,5 k €
Other
Workforce	2,0 ETP	+53.8%	1,3 ETP	-35.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Conrad Pharma

Director · 0536.875.697

Represented by Vanessa Pluym

Active

Philippe Verzele

Director

Active

Ended mandates

GOUWY CONSULTING

Manager · since 01 avril 2011 · 0834.746.465

Represented by Nicolas Gouwy

Ended

GOUWY CONSULTING

Manager · since 01 avril 2011 · 0834.746.465

Represented by Nicolas Gouwy

Ended

Conrad Pharma

Manager · 0536.875.697

Represented by Vanessa Pluym

Ended

Conrad Pharma

Manager · 0536.875.697

Represented by Vanessa Pluym

Ended

Other companies at this address

Diependale 8 9700 Oudenaarde

Company	CBE no.
Conrad Pharma● Active	0536.875.697
DECAPHAR● Active	0843.302.261
GEVA PHARMA● Active	0427.597.576
VERZELE PHARMA ZWALM● Active	0475.231.407

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2026	28/08/2025	12/07/2024	05/07/2023	24/08/2022	26/08/2021
General meeting	24/08/2026	27/06/2025	28/06/2024	30/06/2023	16/08/2022	30/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 18 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	24/08/2026	28/08/2026	Dutch	PDF
Abridged model	31/12/2024	27/06/2025	28/08/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	12/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	05/07/2023	Dutch	PDF
Abridged model	31/12/2021	16/08/2022	24/08/2022	Dutch	PDF
Abridged model	31/12/2020	30/07/2021	26/08/2021	Dutch	PDF
Abridged model	31/12/2019	27/08/2020	14/09/2020	Dutch	PDF
Abridged model	31/12/2018	30/08/2019	23/09/2019	Dutch	PDF
Micro model	31/12/2017	31/07/2018	31/08/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	24/06/2016	31/08/2016	Dutch	PDF
Abridged model	31/12/2014	26/06/2015	31/08/2015	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	18/07/2014	Dutch	PDF
Abridged model	31/12/2012	30/06/2013	30/08/2013	Dutch	PDF
Abridged model	31/12/2011	30/06/2012	14/09/2012	Dutch	PDF
Abridged model	31/12/2010	24/06/2011	14/07/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	28/07/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	28/07/2009	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Conrad Pharma

Director · 0536.875.697

Represented by Vanessa Pluym

Active

Philippe Verzele

Director

Active

Ended mandates

GOUWY CONSULTING

Manager · since 01 avril 2011 · 0834.746.465

Represented by Nicolas Gouwy

Ended

GOUWY CONSULTING

Manager · since 01 avril 2011 · 0834.746.465

Represented by Nicolas Gouwy

Ended

Conrad Pharma

Manager · 0536.875.697

Represented by Vanessa Pluym

Ended

Conrad Pharma

Manager · 0536.875.697

Represented by Vanessa Pluym

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates24/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/11/2017
BENAMING - MAATSCHAPPELIJKE ZETEL - DOEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates20/04/2011
BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Other12/01/2009
DIVERSEN
PDF
Other09/04/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202538,4 k €↑
2024
Annual accounts 202424,4 k €↓
2023
Annual accounts 202338,4 k €↓
2022
Annual accounts 202264,9 k €↑
2021
Annual accounts 202117,7 k €↓
2020
Annual accounts 202047,5 k €↓
2019
Annual accounts 201950,1 k €↑
2018
Annual accounts 201833,1 k €↑
2017
Annual accounts 2017-54,6 k €↑
2016
Annual accounts 2016-58,6 k €↓
2015
Annual accounts 201524 k €↑
2014
Annual accounts 2014602,4 €↑
2013
Annual accounts 2013-7,8 k €↓
2012
Annual accounts 20129,2 k €↑
2011
Annual accounts 20112,1 k €↓
2010
Annual accounts 201037 k €↑
2009
Annual accounts 200932,3 k €↑
2008
Annual accounts 200820,9 k €
28/03/2008
IncorporationPrivate limited company

VERZELE PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline